These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10655047)

  • 1. Pushing the envelope on lipodystrophy.
    Flier JS
    Nat Genet; 2000 Feb; 24(2):103-4. PubMed ID: 10655047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.
    Shackleton S; Lloyd DJ; Jackson SN; Evans R; Niermeijer MF; Singh BM; Schmidt H; Brabant G; Kumar S; Durrington PN; Gregory S; O'Rahilly S; Trembath RC
    Nat Genet; 2000 Feb; 24(2):153-6. PubMed ID: 10655060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the LMNA gene encoding lamin A/C.
    Genschel J; Schmidt HH
    Hum Mutat; 2000 Dec; 16(6):451-9. PubMed ID: 11102973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutations of the lamin A/C gene causing familial partial lipodystrophy: significance for the development of hyperlipidemia and insulin resistant diabetes mellitus].
    Genschel J; Lochs H; Schmidt HH
    Z Gastroenterol; 2000 Apr; 38(4):341-3. PubMed ID: 10820868
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-nucleotide polymorphisms of the nuclear lamina proteome.
    Hegele RA; Yuen J; Cao H
    J Hum Genet; 2001; 46(6):351-4. PubMed ID: 11393540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome.
    Hegele RA
    Mol Genet Metab; 2000 Dec; 71(4):539-44. PubMed ID: 11136544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin.
    Holt I; Clements L; Manilal S; Brown SC; Morris GE
    Eur J Hum Genet; 2001 Mar; 9(3):204-8. PubMed ID: 11313760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear envelope-related lipodystrophies.
    Guénantin AC; Briand N; Bidault G; Afonso P; Béréziat V; Vatier C; Lascols O; Caron-Debarle M; Capeau J; Vigouroux C
    Semin Cell Dev Biol; 2014 May; 29():148-57. PubMed ID: 24384368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.
    Bonne G; Mercuri E; Muchir A; Urtizberea A; Bécane HM; Recan D; Merlini L; Wehnert M; Boor R; Reuner U; Vorgerd M; Wicklein EM; Eymard B; Duboc D; Penisson-Besnier I; Cuisset JM; Ferrer X; Desguerre I; Lacombe D; Bushby K; Pollitt C; Toniolo D; Fardeau M; Schwartz K; Muntoni F
    Ann Neurol; 2000 Aug; 48(2):170-80. PubMed ID: 10939567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear envelope, nuclear lamina, and inherited disease.
    Worman HJ; Courvalin JC
    Int Rev Cytol; 2005; 246():231-79. PubMed ID: 16164970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima Indians.
    Weyer C; Wolford JK; Hanson RL; Foley JE; Tataranni PA; Bogardus C; Pratley RE
    Mol Genet Metab; 2001 Mar; 72(3):231-8. PubMed ID: 11243729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
    Hegele RA; Cao H; Anderson CM; Hramiak IM
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
    Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene.
    Vigouroux C; Auclair M; Dubosclard E; Pouchelet M; Capeau J; Courvalin JC; Buendia B
    J Cell Sci; 2001 Dec; 114(Pt 24):4459-68. PubMed ID: 11792811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies.
    Maraldi NM; Lattanzi G; Capanni C; Columbaro M; Merlini L; Mattioli E; Sabatelli P; Squarzoni S; Manzoli FA
    Eur J Histochem; 2006; 50(1):1-8. PubMed ID: 16584978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease.
    Jakobs PM; Hanson EL; Crispell KA; Toy W; Keegan H; Schilling K; Icenogle TB; Litt M; Hershberger RE
    J Card Fail; 2001 Sep; 7(3):249-56. PubMed ID: 11561226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from human mutations in PPARgamma.
    Hegele RA
    Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S31-5. PubMed ID: 15711581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from lipodystrophy: LMNA, encoding lamin A/C, in HIV therapy-associated lipodystrophy.
    Behrens GM; Lloyd D; Schmidt HH; Schmidt RE; Trembath RC
    AIDS; 2000 Aug; 14(12):1854-5. PubMed ID: 10985325
    [No Abstract]   [Full Text] [Related]  

  • 19. Nuclear envelope proteins and neuromuscular diseases.
    Ostlund C; Worman HJ
    Muscle Nerve; 2003 Apr; 27(4):393-406. PubMed ID: 12661041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life at the edge: the nuclear envelope and human disease.
    Burke B; Stewart CL
    Nat Rev Mol Cell Biol; 2002 Aug; 3(8):575-85. PubMed ID: 12154369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.